120 related articles for article (PubMed ID: 15361211)
1. Doppler study of myometrium in invasive gestational trophoblastic disease.
Oguz S; Sargin A; Aytan H; Kelekci S; Dumanli H
Int J Gynecol Cancer; 2004; 14(5):972-9. PubMed ID: 15361211
[TBL] [Abstract][Full Text] [Related]
2. Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients.
Qin J; Zhang S; Poon L; Pan Z; Luo J; Yu N; Wang L; Wu X; Cheng X; Xie X; Lu Y; Lu W
Ultrasound Obstet Gynecol; 2021 May; 57(5):829-839. PubMed ID: 32385928
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of contrast-enhanced color Doppler ultrasonography in invasive and noninvasive gestational trophoblastic diseases: a preliminary study.
Emoto M; Sadamori R; Hachisuga T; Kawarabayashi T; Miyamoto S
J Reprod Med; 2011; 56(5-6):224-34. PubMed ID: 21682118
[TBL] [Abstract][Full Text] [Related]
4. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
[TBL] [Abstract][Full Text] [Related]
5. Conservative Chemotherapy in Gestational Trophoblastic Disease: Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy.
Byun SW; Park TC; Bae SN
Int J Gynecol Cancer; 2016 May; 26(4):790-5. PubMed ID: 27057813
[TBL] [Abstract][Full Text] [Related]
6. Successful pregnancy after treatment of a cervical gestational trophoblastic neoplasia: a case report.
Chua AA; Soriano-Estrella AL
J Reprod Med; 2012; 57(1-2):85-8. PubMed ID: 22324277
[TBL] [Abstract][Full Text] [Related]
7. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
[TBL] [Abstract][Full Text] [Related]
8. Transvaginal ultrasound predicts delayed response to chemotherapy and drug resistance in stage I low-risk trophoblastic neoplasia.
Cavoretto P; Gentile C; Mangili G; Garavaglia E; Valsecchi L; Spagnolo D; Montoli S; Candiani M
Ultrasound Obstet Gynecol; 2012 Jul; 40(1):99-105. PubMed ID: 22262502
[TBL] [Abstract][Full Text] [Related]
9. Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.
Bianconi MI; Otero S; Moscheni O; Alvarez L; Storino C; Jankilevich G
J Reprod Med; 2012; 57(7-8):341-9. PubMed ID: 22838252
[TBL] [Abstract][Full Text] [Related]
10. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of a persistent mole with myometrial invasion by direct injection of methotrexate.
Su WH; Wang PH; Chang SP
Eur J Gynaecol Oncol; 2001; 22(4):283-6. PubMed ID: 11695810
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Song SQ; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of transvaginal ultrasound for the evaluation of myometrial invasion in endometrial carcinoma.
Ruangvutilert P; Sutantawibul A; Sunsaneevithayakul P; Boriboonhirunsarn D; Chuenchom T
J Med Assoc Thai; 2004 Jan; 87(1):47-52. PubMed ID: 14971534
[TBL] [Abstract][Full Text] [Related]
14. Depth of myometrial invasion in endometrial cancer: preoperative assessment by transvaginal ultrasonography.
Gordon AN; Fleischer AC; Reed GW
Gynecol Oncol; 1990 Dec; 39(3):321-7. PubMed ID: 2258078
[TBL] [Abstract][Full Text] [Related]
15. Necrosis of myometrial choriocarcinoma with fulminating sepsis complicating chemotherapy for trophoblastic tumor.
Odunsi KO; Peck LL; Kohorn EI; Parkash V; Cracchiolo B; Chambers JT; Taylor KJ
Gynecol Oncol; 1998 Jul; 70(1):100-4. PubMed ID: 9698483
[TBL] [Abstract][Full Text] [Related]
16. Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1998 Jan; 43(1):69-74. PubMed ID: 9475152
[TBL] [Abstract][Full Text] [Related]
17. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
18. Fertility-sparing surgery for persistent gestational trophoblastic neoplasia in the myometrium: a case report.
Rojas-Espaillat L; Houck KL; Hernandez E; Berkowitz RS
J Reprod Med; 2007 May; 52(5):431-4. PubMed ID: 17583247
[TBL] [Abstract][Full Text] [Related]
19. Comparing and evaluating the efficacy of methotrexate and actinomycin D as first-line single chemotherapy agents in low risk gestational trophoblastic disease.
Lee YJ; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Gynecol Oncol; 2017 Mar; 28(2):e8. PubMed ID: 27819410
[TBL] [Abstract][Full Text] [Related]
20. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
Lurain JR; Brewer JI
Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]